Tissue Specific Promoters in Colorectal Cancer

Area of Science:

• Oncology
• Gene Therapy
• Molecular Biology

Background:

• Colorectal carcinoma is a globally prevalent cancer, often resistant to conventional chemotherapy.
• Advanced stages of colorectal cancer exhibit poor response to chemotherapy, leading to significant tissue damage.

Purpose of the Study:

• To review the potential of suicide gene therapy for colorectal carcinoma treatment.
• To discuss the role of tumor-specific promoters in enhancing gene therapy specificity and efficacy.

Main Methods:

• Review of current literature on suicide gene therapy in colorectal cancer.
• Analysis of tumor-specific promoters for targeted gene delivery.
• Evaluation of gene therapy strategies for colorectal carcinoma.

Main Results:

• Suicide gene therapy can potentiate cytotoxic effects in colorectal cancer.
• Targeting and specificity remain challenges in current gene therapy approaches.
• Tumor-specific promoters show potential for localized therapeutic gene expression.

Conclusions:

• Gene therapy, particularly with tumor-specific promoters, holds significant potential for improving colorectal carcinoma treatment.
• Targeted delivery of therapeutic genes via specific promoters can enhance efficacy and minimize off-target effects.